Multi-channel Financing and Payment Mechanism Reform for Tuberculosis Prevention and Control: A SWOT Analysis of the National Pilot in Baoding, China

Tuberculosis is an ancient disease that thrives where poverty is deep and healthcare is fragile. It does not just attack the lungs; it attacks the financial stability of the families it touches. When a person falls ill, the cost of medicine and the loss of income can push a household into destitution, creating a cycle where the sick cannot afford to get better, and the poor remain sick. For decades, the global effort to stop this disease has focused on finding new drugs and better vaccines, but a critical piece of the puzzle has often been missing: how to pay for the care in a way that actually works. Traditional systems often pay doctors for every test they order and every day a patient stays in a hospital. This approach can accidentally encourage unnecessary procedures and fragment care, leaving the patient to navigate a maze of bills while the disease spreads. The question facing health leaders is how to restructure the money flow so that it rewards keeping people healthy and getting them cured, rather than just treating them when they are already very sick.

In the city of Baoding, China, researchers set out to test a new way of handling the money for tuberculosis care. They studied a pilot program that changed the rules of the game for how hospitals and clinics are paid. Instead of paying for each individual service, the new system gave providers a single, fixed amount of money to cover the entire course of treatment for a patient, from the first diagnosis to the final check-up. This lump sum was designed to cover both medical care and public health services, encouraging doctors to work together across different departments to ensure the patient finished their treatment successfully. The researchers, led by a team from Baoding People's Hospital, spent years watching how this system played out in the real world. They interviewed doctors, insurance officials, and patients, and they looked closely at the numbers to see if the new approach actually helped.

The results of this experiment were encouraging. Under the new system, the number of patients who completed their full course of treatment rose significantly, reaching nearly ninety-nine percent. At the same time, the rate at which doctors tested patients for drug-resistant strains of the bacteria reached one hundred percent, ensuring that the right medicine was prescribed from the start. Perhaps most importantly for the long-term health of the system, the medical insurance fund, which had been running a deficit, began to generate a surplus. This happened because the new payment model discouraged unnecessary tests and kept patients out of the hospital when they could be treated on an outpatient basis. The average cost for treating a single patient went down, and the medical insurance fund achieved a surplus by 2023, indicating improved efficiency in fund utilization.

However, the story is not one of a perfect solution. The researchers found that while the system worked well for the standard cases it was designed to cover, it left some gaps. About forty percent of the costs for some patients still fell outside the fixed payment package, meaning families still had to pay for certain medicines or services that the new plan did not include. The doctors and hospital staff also reported that the new system created more paperwork, adding roughly five hours of administrative work to their weekly schedules. Furthermore, the ability to perform rapid genetic testing for drug resistance was not yet strong enough in the primary care clinics, creating a bottleneck where patients might face delays in receiving targeted therapy. The study also noted that the funding for this program relied heavily on specific projects rather than being a permanent part of the national budget, which raises questions about whether the system can survive if that special funding disappears.

The researchers concluded that the Baoding model offers a powerful blueprint for how to fight tuberculosis in resource-limited settings. By tying the payment to the successful completion of treatment and integrating medical care with public health prevention, the city managed to improve health outcomes while saving money. The system proved that it is possible to align the financial incentives of hospitals with the health needs of the community. Yet, the team was clear that this is a work in progress. To make the model sustainable and fair for everyone, the list of covered services needs to be expanded to include more essential medicines, the paperwork needs to be simplified, and the diagnostic tools in local clinics need to be upgraded. If these adjustments are made, the experience in Baoding could serve as a guide for other regions struggling to balance the fight against infectious disease with the economic realities of their populations. The path forward is not about finding a magic bullet, but about carefully refining a system that has already shown it can make a real difference.